All participants who provided informed consent entered and completed the study in their original group assignment. The baseline MRI for one participant in the control group was eliminated because of movement artifact. The clinical measures of strength and SMC were complete for all 32 participants.All participants had a frequency set at 33Hz with pulse width ranging from 25 to 100μs. Participants used NMES‐assisted gait daily for a mean of 6.2 (SD 3.2) hours over the 8‐week intervention period. There were no reported unintended effects or adverse events using the NMES device.